We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$851M
AUM Growth
-$105M
Cap. Flow
+$44.2M
Cap. Flow %
5.19%
Top 10 Hldgs %
47.53%
Holding
835
New
170
Increased
157
Reduced
172
Closed
270

Top Buys

Rank Stock Value
1
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
+$24.3M
2
STOK icon
Stoke Therapeutics
STOK
+$22.8M
3
TIOA
Tio Tech A Class A Ordinary Share
TIOA
+$22.1M
4
SCPH
scPharmaceuticals
SCPH
+$20.6M
5
AAC
Ares Acquisition Corporation
AAC
+$13.3M

Top Sells

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.8M
2
SCPL
SciPlay Corporation Class A Common Stock
SCPL
+$25.2M
3
CTLP
Cantaloupe
CTLP
+$12.3M
4
INVZ icon
Innoviz Technologies
INVZ
+$10.9M
5
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
+$8.76M

Sector Composition

Rank Sector Weight
1 Healthcare 38.46%
2 Financials 25.66%
3 Materials 12.69%
4 Consumer Discretionary 4.54%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADTHW
251
DELISTED
AdTheorent Holding Co Warrants
ADTHW
$35.3K ﹤0.01%
294,084
-54,701
-16% -$8.48K
BRACR
252
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
$34.9K ﹤0.01%
234,212
+2,450
+1% +$382
DNA.WS
253
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$34.3K ﹤0.01%
190,618
-60,408
-24% -$13.8K
GSRMR
254
DELISTED
GSR II Meteora Acquisition Corp. Right
GSRMR
$33.6K ﹤0.01%
+39,562
New +$56K
PPHPW
255
DELISTED
PHP Ventures Acquisition Corp. Warrants
PPHPW
$33.4K ﹤0.01%
+341,576
New +$32.7K
GROV.WS
256
DELISTED
Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50
GROV.WS
$33.2K ﹤0.01%
611,017
+338,308
+124% +$22.5K
BFAC.WS
257
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$33.1K ﹤0.01%
330,587
+300
+0.1% +$29
JWSM.WS
258
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$32.9K ﹤0.01%
302,634
-205,036
-40% -$18.5K
SONDW
259
DELISTED
Sonder Holdings Inc Warrants
SONDW
$32.8K ﹤0.01%
455,644
-21,745
-5% -$2.69K
NOTE.WS
260
DELISTED
FiscalNote Holdings Warrants
NOTE.WS
$32K ﹤0.01%
+100,000
New +$50K
HHLA.WS
261
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$31.6K ﹤0.01%
503,940
+50,664
+11% +$4.18K
CLRCR
262
DELISTED
ClimateRock Right
CLRCR
$31.5K ﹤0.01%
273,686
-4,900
-2% -$638
HMACR
263
DELISTED
Hainan Manaslu Acquisition Corp. Right
HMACR
$31.3K ﹤0.01%
164,739
+65,239
+66% +$9.03K
NOGN
264
DELISTED
Nogin, Inc. Common Stock
NOGN
$30.6K ﹤0.01%
+11,250
New +$136K
ZTAQW
265
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$30.3K ﹤0.01%
172,965
-149,101
-46% -$25.1K
SVIIR
266
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$30K ﹤0.01%
150,000
-160,000
-52% -$30.3K
WINVW
267
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$29.3K ﹤0.01%
991,531
-34,611
-3% -$793
EACPW
268
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$29.2K ﹤0.01%
968,724
-92,469
-9% -$4.64K
YOTAW
269
DELISTED
Yotta Acquisition Corporation Warrant
YOTAW
$28.8K ﹤0.01%
396,686
-24,955
-6% -$1.88K
AERTW
270
Aeries Technology Warrant
AERTW
$887K
$28.8K ﹤0.01%
+261,412
New +$22.7K
MKFG.WS
271
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$28.5K ﹤0.01%
190,193
+1,300
+0.7% +$250
HIPO.WS
272
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$28.1K ﹤0.01%
503,674
-17,029
-3% -$906
OPA.WS
273
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$27.8K ﹤0.01%
370,486
-167,302
-31% -$7.26K
JAQCW
274
DELISTED
Jupiter Acquisition Corporation Warrants
JAQCW
$27.8K ﹤0.01%
310,249
+138,197
+80% +$10.9K
NFNT.WS
275
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$27.8K ﹤0.01%
154,406
-51,600
-25% -$6.87K
9 10
11
12 13

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2023 Portfolio in Review

As of Q1 2023, Cowen and Company held 835 positions worth $851M, down 11% from $956M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cowen and Company deployed $44.2M of net new capital in Q1 2023, opening 170 new positions and adding to 157 existing holdings. Its largest new stake was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was SciPlay Corporation Class A Common Stock, an estimated $25.2M trimmed.

  • Cowen and Company's largest Q1 2023 buy was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.
  • Cowen and Company added most to Stoke Therapeutics in Q1 2023, an estimated $22.8M increase.
  • Cowen and Company's biggest Q1 2023 reduction was SciPlay Corporation Class A Common Stock, cutting an estimated $25.2M.
  • Cowen and Company fully exited DCP Midstream, LP in Q1 2023, selling an estimated $58.8M.
  • Cowen and Company's ten largest holdings make up 48% of its $851M portfolio in Q1 2023.
  • Cowen and Company opened 170 new positions and closed 270 in Q1 2023.
  • Cowen and Company's portfolio value fell 11% quarter-over-quarter to $851M.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.